Evaluation of a Recombinant Factor IX Product, APVO101, in Previously-Treated Pediatric Patients With Hemophilia B
Clinical trial NCT03855280 · COMPLETED
Trial details
- NCT number
- NCT03855280
- Sponsor
- Medexus Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-16
- Primary completion
- 2022-07-04
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.